Perfusion Market Size was valued at USD 1.36 Billion in 2023. The Global Perfusion industry is projected to grow from USD 1.44 Billion in 2024 to USD 2.21 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.18% during the forecast period (2024 - 2032). Perfusion is a process of delivering oxygenated blood to all tissues. This technique is used in cardiac surgery where perfusion experts employ artificial blood pumps to thrust patients' blood through their body tissue by replacing the function of the heart while the cardiac surgeon operates.
Perfusion can be used as chemotherapy technique for the treatment of melanoma occurring in arm or legs. With the help of this technique, flow of blood to and from the limb is stopped for a while by creating a band, and anticancer drugs are put directly in blood of the limb. This helps patients to receive a high dose of drugs in the area where the melanoma had occurred.
Poor perfusion causes numerous severe health problems such as deep vein thrombosis and coronary artery disease. It has been observed that during major surgeries such as cardiothoracic surgeries and organ transplant, maintenance of perfusion is vital and to maintain this many preservation methods are being used. The two most important methods are machine perfusion (MP) and static cold storage (SCS). Although SCS is a highly adopted process for preservation, it is inefficient to maintain normal functioning of organs at high-risk. Hypothermic machine perfusion (HMP) has emerged as an effective solution to curb such problems. Every year more than one hundred thousand perfusion procedures are being performed around the globe.
Rising number of chronic diseases cases such as cardiac diseases, liver and kidney diseases often leads to organ transplant and is one of the major driver of the Perfusion Systems market. Moreover, rising cases of organ failure due to other factors such as improper diet, smoking and consumption of alcohol has led to the demand of effective perfusion systems. As per National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than 661,000 Americans have kidney failure which is a major driving force for the Perfusion Systems market. However, lack of awareness regarding perfusion systems in developing countries can limit the growth of this market.
The perfusion market is growing steadily and is expected to continue its growth during the forecast period. perfusion market is expected to grow at the CAGR of 2.55% during the forecast period and is estimated to reach around 580.31 million by 2030.
Perfusion market has been segmented on the basis of type which comprise of cardiopulmonary bypass, extracorporeal membrane oxygenation, isolated limb perfusion and others. Cardiopulmonary bypass is further sub-segmented into heart-lung machines, oxygenators, perfusion pumps, monitoring systems, cannulas, and other components.
On the basis of application, Perfusion market is segmented into lungs, heart, liver, kidneys and others. On the basis of device type, the market has been segmented into hypothermic machine perfusion, normothermic machine perfusion and others. On the basis of end user, it is segmented into hospital, specialty clinics, medical research centers, academic institutes, and others.
Considering the global scenario of the Perfusion Systems market, the Americas is the largest market of perfusion. The Americas mainly includes North America and Latin America. North America is a dominating region across the global market. Some major factors like technological advancement and growing number of organ transplants are major driving factors for the growth of the perfusion market. Europe is the second highest revenue generating region in the Perfusion Systems market. Europe is mainly divided into Eastern Europe and Western Europe. More developed countries of Western Europe like Germany, France and UK are holding major market share while the market in East European countries are also growing significantly. Due to the developing healthcare infrastructure, increasing healthcare expenditure, and growing adoption of new techniques for perfusion and organ preservations has led to the fastest growth of the Asia Pacific perfusion market. Middle East & Africa is expected to grow slow growth in this market. Middle Eastern countries like UAE and Saudi are dominating this market, it is mainly due to availability of top class medical facilities, high income and government support to improve public health.
| Report Attribute/Metric | Details |
| Market Size | USD 2.21 Billion |
| CAGR | 5.18% (2024-2032) |
| Base Year | 2019 |
| Forecast Period | 2024-2032 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Device Type, Applications, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Getinge AB (Sweden), Medtronic (Ireland), LivaNova PLC (U.K.), Terumo Medical Corporation (Japan), XENIOS AG (Germany), Lifeline Scientific, Inc. (U.S.), XVIVO Perfusion (Sweden), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), Ala Science (U.S.) and others |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers | Rising number of chronic diseases cases such as cardiac diseases, liver and kidney diseases often leads to organ transplantRising cases of organ failure |
Frequently Asked Questions (FAQ) :
Perfusion is a Process of Delivering Oxygenated Blood to all parts of the Body. Perfusion is Widely Used During Cardiac Medical Procedures to Replace the Function of The Heart, Which Is Being Operated Upon.
Perfusion Market Is Expected To Exhibit A Steady 5.18% Cagr Over The Forecast Period From 2024-2032.
The Growing Prevalence of Cardiovascular Diseases Is The Major Driver For The Perfusion Market.
North America is the Dominant Regional Market for Perfusion Technology And Devices.
Leading Players in The Perfusion Market Include Xvivo Perfusion, Livanova Plc, And Medtronic, Among Others.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
